Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.
| Website: | www.criver.com |
| Email: | todd.spencer@crl.com |
| Main Phone: | +1 781 222-6000 |
| Address: | 251 Ballardvale Street |
| State: | MA |
| City / Town: | Wilmington |
| Country: | USA |
| Postal Code: | 01887 |
| Exchange: | NYE |
| CEO: | James C. Foster |
| Employees: | 14700 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
Gathering Data... Please wait Charles River Laboratories is a leading provider of drug discovery and development services. With roughly 50% of market share worldwide, the research model and services segment is the leading provider of animal models for laboratory testing. About half of the company's revenue comes from drug discovery and preclinical testing, and one fourth comes from the manufacturing support segment.
| Website: | www.criver.com |
| Email: | todd.spencer@crl.com |
| Main Phone: | +1 781 222-6000 |
| Address: | 251 Ballardvale Street |
| State: | MA |
| City / Town: | Wilmington |
| Country: | USA |
| Postal Code: | 01887 |
| Exchange: | NYE |
| CEO: | James C. Foster |
| Employees: | 14700 |
| NAICS: | Research and Development in Biotechnology (except Nanobiotechnology)(541714) |
| Last Price 138.64 | Change $ 0.68 | Change % 0.49 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 138.64 | High 140.10 | Low 138.39 | Prev Close 137.96 |
| Last Trade | Volume 600,802 | 52 Wk Hi 149.07 | 52 Wk Low 103.00 |
| Market Cap 6.8 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 48,807,170.00 | EPS (TTM) 4.44 | PE Ratio 30.20 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 41 | 1000 |
| Number of Buys | 18 | 61 |
| Number of Sells | 23 | 939 |
| Net Activity | 23262 | 64809 |
| Last 10 Buys | Shares |
|---|---|
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| James C. Foster | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| George E. Massaro | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 129 | 129 | 129 | 129 |
| Low Target Price Estimate | 102 | 102 | 102 | 102 |
| Mean Target Price Estimate | 118.25 | 118.25 | 118.25 | 118.25 |
| Standard Deviation | 8.65 | 8.65 | 8.65 | 8.65 |
| Date of Most Recent Estimate | 05/31/18 | 05/11/18 | 05/11/18 | 05/31/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 8-K/A | Amendment to a previously filed 8-K | 33 | 2018-06-14 |
| 8-K | Report of unscheduled material events or corporate changes. | 4 | 2018-06-14 |
| SD | Specialized Disclosure Report | 5 | 2018-05-31 |
| 4/A | Amendment to a previously filed Form 4 | 1 | 2018-05-24 |
| S-8 | Securities offered to employees under employee benefit plans | 10 | 2018-05-18 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-15 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 9 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 6 | 6 | 5 | 6 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.92 | 1.92 | 1.77 | 1.8 |
© 2019 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
